Luana Forleo

Dr. Luana Forleo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
AMALESSIA MONGELLI
ALESSIA MONGELLI
VBVeronica Barbi
Veronica Barbi
MZMichela Gottardi Zamperla
Michela Gottardi Zamperla
SASandra Atlante
Sandra Atlante
LFLuana Forleo
Luana Forleo
Carlo GaetanoCarlo Gaetano
Carlo Gaetano
Introduction & Background the SARS-CoV-2 infection determines the COVID19 syndrome characterized, in the worst cases, by severe respiratory distress, pulmonary and cardiac fibrosis, inflammatory cytokines release, and immunosuppression. This condition has led to the death of about 2.15% of the total infected world population so far. Among survivors, the presence of the so-called persistent post-COVID19 syndrome (PPCS) is a common finding. In patients who survived the SARS-CoV-2 infection, overt PPCS presents one or more symptoms such as fatigue, dyspnea, memory loss, sleep disorders, and difficulty concentrating. The pathophysiology of PPCS is currently poorly understood, and whether epigenetic mechanisms are involved in this process is unexplored. Methods & Results In this study, a cohort of 117 COVID19 survivors (post-COVID19) and 144 non-infected volunteers (COVID19-free) were analyzed using pyrosequencing of defined CpG islands previously identified as suitable for biological age determination. Besides, telomere length (TL) and ACE2 and DPP-4 receptor expression were determined. The results show a consistent biological age increase in the post-COVID19 population (58,44 ± 14,66 ChronoAge Vs. 67,18 ± 10,86 BioAge, P<0,0001), determining a DeltaAge acceleration of 10,45 ± 7,29 years (+5.25 years above range of normality) compared to 3,68 ± 8,17 years for the COVID19-free population (P<0,0001). A significant telomere shortening parallels this finding in the post-COVID19 cohort compared to COVID19-free subjects (post-COVID19 TL: 3,03 ± 2,39 Kb vs. COVID19-free: 10,67 ± 11,69 Kb; P<0,0001). Additionally, ACE2 expression was decreased in post-COVID19 patients compare to COVID19-free, while DPP-4 did not change. Conclusion In light of these observations, we hypothesize that some epigenetic alterations are associated with the post-COVID19 condition, particularly in the youngers (<60 years). Although the consequences of such modifications on the long-term clinical outcome remain unclear, this finding might help indicating a direction to investigate the pathophysiology at the onset of the persistent post-COVID19 syndrome.

31 January 2023 in Biology
Verified
Journal Article
Open access
PDF file
Valentina MangoliniValentina Mangolini
Valentina Mangolini
Alice GualerziAlice Gualerzi
Alice Gualerzi
SPSilvia Picciolini
Silvia Picciolini
Francesca RodàFrancesca Rodà
Francesca Rodà
APAngela Del Prete
Angela Del Prete
MBMarzia Bedoni
Marzia Bedoni
Extracellular vesicles (EVs) are natural nanoparticles secreted under physiological and pathological conditions. Thanks to their diagnostic potential, EVs are increasingly being studied as biomarkers of a variety of diseases, including neurological disorders. To date, most studies on EV biomarkers use blood as the source, despite different disadvantages that may cause an impure isolation of the EVs. In the present article, we propose the use of saliva as a valuable source of EVs that could be studied as biomarkers in an easily accessible biofluid. Using a comparable protocol for the isolation of EVs from both liquid biopsies, salivary EVs showed greater purity in terms of co-isolates (evaluated by nanoparticle tracking analysis and Conan test). In addition, Raman spectroscopy was used for the identification of the overall biochemical composition of EVs coming from the two different biofluids. Even considering the limited amount of EVs that can be isolated from saliva, the use of Raman spectroscopy was not hampered, and it was able to provide a comprehensive characterization of EVs in a high throughput and repeatable manner. Raman spectroscopy can thus represent a turning point in the application of salivary EVs in clinics, taking advantage of the simple method of collection of the liquid biopsy and of the quick, sensitive and label-free biophotonics-based approach.

31 October 2023 in The Analyst
Verified
Journal Article
Closed access
PDF file
SPSilvia Picciolini
Silvia Picciolini
Francesca RodàFrancesca Rodà
Francesca Rodà
Alice GualerziAlice Gualerzi
Alice Gualerzi
Valentina MangoliniValentina Mangolini
Valentina Mangolini
LFLuana Forleo
Luana Forleo
MBMarzia Bedoni
Marzia Bedoni
The SPRi analysis was optimized to study the interactions between mApoE-functionalized liposomes and receptors present in the brain and on monocytes and lymphocytes, demonstrating to be an excellent technique for characterization of liposomes.

Verified
Journal Article
Open access
PDF file
LFLuana Forleo
Luana Forleo
SPSilvia Picciolini
Silvia Picciolini
Alice GualerziAlice Gualerzi
Alice Gualerzi
EBElvia Battaglia
Elvia Battaglia
ECElena Compalati
Elena Compalati
MBMarzia Bedoni
Marzia Bedoni
Obstructive sleep apnea syndrome (OSAS) is a respiratory disorder in middle-aged and elderly populations, marked by breathing interruptions during sleep. Diagnosis faces challenges due to the absence of specific biomarkers and increasing screening demands. This study aims to identify salivary biomarkers for the diagnosis and monitoring of OSAS using a simplified, rapid, and non-invasive method. Saliva from 51 OSAS patients and 34 healthy controls (CTR) was analyzed using Raman spectroscopy, which identified disease-specific biochemical fingerprints. Raman analysis revealed differences between the OSAS and CTR groups. The area under the curve of the lactic acid peak (920 cm−1) appeared higher in the OSAS group compared to the CTR group, suggesting potential diagnostic relevance. Significant correlations were found between biomolecular and clinical data, and a final linear model indicated that the lactate concentration significantly influenced the canonical variable. The Raman-based approach and the lactic acid peak represent a promising tool for OSAS diagnosis, monitoring, and supporting decisions in pulmonary rehabilitation. However, further investigation with a larger cohort is needed to clarify the observed discrepancies.

11 July 2024 in Chemosensors
Verified
Journal Article
Open access
PDF file
Francesca RodàFrancesca Rodà
Francesca Rodà
Alice GualerziAlice Gualerzi
Alice Gualerzi
SPSilvia Picciolini
Silvia Picciolini
LFLuana Forleo
Luana Forleo
Valentina MangoliniValentina Mangolini
Valentina Mangolini
MBMarzia Bedoni
Marzia Bedoni
The rapid spread of SARS-COV-2 and the millions of worldwide deaths and hospitalizations have prompted an urgent need for the development of screening tests capable of rapidly and accurately detecting the virus, even in asymptomatic people. The easy collection and the biomarker content of saliva, together with the label-free and informative power of surface-enhanced Raman spectroscopy (SERS) analysis have driven the creation of point-of-care platforms capable of identifying people with COVID-19. Indeed, different salivary fingerprints were observed between uninfected and infected people. Hence, we performed a retrospective analysis of SERS spectra from salivary samples of COVID-19-infected and -vaccinated subjects to understand if viral components and/or the immune response are implicated in spectral variations. The high sensitivity of the proposed SERS-based method highlighted the persistence of molecular alterations in saliva up to one month after the first positive swab, even when the subject tested negative for the rapid antigenic test. Nevertheless, no specific spectral patterns attributable to some viral proteins and immunoglobulins involved in COVID-19 infection and its progression were found, even if differences in peak intensity, presence, and position were observed in the salivary SERS fingerprint.

27 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KMKrzysztof Mikolajczyk
Krzysztof Mikolajczyk
ABAnna Bereznicka
Anna Bereznicka
LCLiliana Czernek
Liliana Czernek
Alice GualerziAlice Gualerzi
Alice Gualerzi
LFLuana Forleo
Luana Forleo
PMPaweł Migdał
Paweł Migdał
Shiga toxins (Stx) are key virulence factors of Shiga toxin-producing Escherichia coli (STEC), which are responsible for severe foodborne infections that can progress to hemolytic-uremic syndrome (HUS). Currently, no specific anti-toxin therapies are available. In this study, we devised a glycoengineering strategy utilizing Functional-Spacer-Lipid (FSL) conjugates to create small extracellular vesicles (sEVs)-based decoy receptors for Shiga toxin type 1 (Stx1). sEVs isolated from human Caco-2 and HEK293T cells were functionalized with Gb3 trisaccharide (Galα1→4Galβ1→4Glc)-containing FSL conjugates, yielding Gb3-decorated vesicles, displaying the Galα1→4Gal epitope. Characterization of FSL-modified sEVs confirmed that FSL incorporation did not adversely affect sEV morphology, size distribution, or surface charge. Western blotting and bead-assisted flow cytometry verified the presence of exosomal markers (CD9 and CD63) and the Gb3 epitope on modified vesicles. Gb3-tagged sEVs from both cell types exhibited high specificity in binding Stx1B, while control vesicles carrying Galili epitope (Galα1→3Galβ1→4GlcNAc), lacking Stx1B binding, demonstrated negligible binding. Gb3-expressing Caco-2 cell-based assays revealed that Gb3-decorated sEVs markedly reduced Stx1B binding to Caco-2 cells, indicating effective competition with cellular receptors. Furthermore, glycoengineered sEVs did not impair Caco-2 cell viability at concentrations sufficient for Stx1B sequestration. These findings establish FSL-mediated glycoengineering as a rapid and versatile approach for generating sEV-based decoy receptors that effectively bind Stx1B. Gb3-containing human sEVs may serve as an agent for neutralizing Stx1B and potentially other glycan-binding toxins, supporting the development of promising next-generation anti-toxin therapeutics.